PharmAsia News Notable Notes: Japan’s Rising Health Care Funding Gap
This article was originally published in PharmAsia News
Executive Summary
Japanese policy makers should reconsider the country's National Health Insurance plan, which focuses on constraining costs rather than the scope of treatment, if they are to avoid a funding gap created by rising health care costs, according to a report by the economic research and consulting firm McKinsey Global Institute
You may also be interested in...
Japan Unlikely To Relax Dispensing Limits On New Drugs
TOKYO - Even though Japan relaxed prescription drug-dispensing periods in 2002, it continues to limit dispensing for narcotics and for new drugs during the first year of launch - a regulation the U.S. believes is a barrier to trade that inconveniences patients and doctors
Japan Unlikely To Relax Dispensing Limits On New Drugs
TOKYO - Even though Japan relaxed prescription drug-dispensing periods in 2002, it continues to limit dispensing for narcotics and for new drugs during the first year of launch - a regulation the U.S. believes is a barrier to trade that inconveniences patients and doctors
Japan Sees Pharma Research as its Sunrise Sector, Alters Policy to Rev up R&D
TOKYO - The Japanese Ministry of Health, Labor and Welfare will seek budgetary appropriations or allocations for 2009 to extend research funds to companiesfor developing break-though pharmaceutical products as a national project, according to a MHLW official Aug. 5